Publication | Closed Access
Anti-leukemic effects of HDACi Belinostat and HMTi 3-Deazaneplanocin A on human acute promyelocytic leukemia cells
27
Citations
29
References
2017
Year
Hematological MalignancyMedicineMalignant Blood DisorderMixed-phenotype Acute LeukemiaHematologyPharmacologyCell DeathImmunologyHdaci BelinostatPharmacotherapyAnti-cancer AgentOncologyAnti-leukemic EffectsCancer Research
| Year | Citations | |
|---|---|---|
Page 1
Page 1